☰

Dipak S. Pisal, Ph.D. - Publications

Affiliations: 
2012 Pharmaceutical Sciences State University of New York, Buffalo, Buffalo, NY, United States 
Area:
Pharmacy, Immunology
Tree Info Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Kosloski MP, Pisal DS, Mager DE, Balu-Iyer SV. Nonlinear pharmacokinetics of factor VIII and its phosphatidylinositol lipidic complex in hemophilia A mice. Biopharmaceutics & Drug Disposition. 35: 154-63. PMID 24259187 DOI: 10.1002/Bdd.1880  0.703
2013 Kosloski MP, Pisal DS, Mager DE, Balu-Iyer SV. Allometry of factor VIII and informed scaling of next-generation therapeutic proteins. Journal of Pharmaceutical Sciences. 102: 2380-94. PMID 23620343 DOI: 10.1002/Jps.23566  0.679
2012 Pisal DS, Kosloski MP, Middaugh CR, Bankert RB, Balu-Iyer SV. Native-like aggregates of factor VIII are immunogenic in von Willebrand factor deficient and hemophilia a mice. Journal of Pharmaceutical Sciences. 101: 2055-65. PMID 22388918 DOI: 10.1002/Jps.23091  0.696
2012 Peng A, Pisal DS, Doty A, Balu-Iyer SV. Phosphatidylinositol induces fluid phase formation and packing defects in phosphatidylcholine model membranes. Chemistry and Physics of Lipids. 165: 15-22. PMID 22024173 DOI: 10.1016/J.Chemphyslip.2011.10.002  0.66
2011 Pisal DS, Balu-Iyer SV. Phospholipid binding lowers immunogenicity of human recombinant factor VIII in von Willebrand factor knockout mice. Thrombosis and Haemostasis. 105: 1115-8. PMID 21475771 DOI: 10.1160/Th10-09-0628  0.643
2010 Pisal DS, Balu-Iyer SV. Phospholipid binding improves plasma survival of factor VIII. Thrombosis and Haemostasis. 104: 1073-5. PMID 20838749 DOI: 10.1160/Th10-06-0422  0.659
2010 Pisal DS, Kosloski MP, Balu-Iyer SV. Delivery of therapeutic proteins. Journal of Pharmaceutical Sciences. 99: 2557-75. PMID 20049941 DOI: 10.1002/Jps.22054  0.681
2010 Rao G, Iyer V, Kosloski MP, Pisal DS, Shin E, Middaugh CR, Balu-Iyer SV. Use of a folding model and in situ spectroscopic techniques for rational formulation development and stability testing of monoclonal antibody therapeutics. Journal of Pharmaceutical Sciences. 99: 1697-706. PMID 19798762 DOI: 10.1002/Jps.21938  0.691
Show low-probability matches.